Despite the large number of biologics currently available for moderate-to-severe psoriasis,
poor adherence and persistence to therapy represent the main issues for both the clinical …

Psoriatic arthritis is a systemic autoimmune disease, in which a characteristic
heterogeneous inflammatory involvement of entheses and both peripheral and axial joints …

Introduction Given the growing interest and use of interleukin-17 inhibitors (anti-IL17) for the
treatment of psoriatic arthritis (PsA), an observational study has been conducted to …

Axial spondyloarthritis (axSpA) is an inflammatory rheumatic disorder that causes chronic
pain, primarily in the spine and sacroiliac joints. It is characterized by the presence of type 1 …

Background Secukinumab is a biologic disease-modifying antirheumatic drug (bDMARD)
that has demonstrated efficacy in the treatment of axial spondyloarthritis (axSpA, ie …

Tóm tắt Mục tiêu: Xác định một số yếu tố liên quan với tình trạng không đáp ứng với
secukinumab ở bệnh nhân viêm cột sống dính khớp. Đối tượng và phương pháp nghiên …

Axial spondyloarthritis (axSpA) is an inflammatory rheumatic disorder that causes chronic
pain, primarily in the spine and sacroiliac joints. It is characterized by the presence of type 1 …